Andrei Petrov is a Russian scientist representing Affitech's partner IBC Generium. He has a vast knowledge and experience within molecular biology, cell biology and immunology. Andrei Petrov graduated from Moscow State University Chemistry Department in 1995. His PhD thesis was devoted to study of structure and function of telomerase which is ribonucleoprotein complex related to the mechanisms of cellular control over proliferation and senescence. He considerably contributed to the basic research on the subject exploring modern and sophisticated molecular biology and biochemistry methods not used in his laboratory before. Andrei Petrov did his post-doctoral training at the French Oncology Center referred as Institut Gustave Roussy (Villejuif, France) joining the group headed by Yegor Vassetzky. Andrei made a core part of the group to investigate the mechanisms underlying the mysterious type of muscular dystrophy FSHD. During this time (2002-2006) he established a set of important tools for studying the chromatin structure, its epigenetic features and reorganization, transcriptional regulation accounted for development of the pathology where mostly children are targeted. Andrei substantially contributed to the overall performance of the research group at that time and made it progress faster than ever before.